Cargando…
Risk factors for the development of depression in patients with hepatitis C taking interferon-α
Interferon-α, currently used for the treatment of hepatitis C, is associated with a substantially elevated risk of depression. However, not everyone who takes this drug becomes depressed, so it is important to understand what particular factors may make some individuals more ‘at risk’ of developing...
Autores principales: | Smith, Kimberley J, Norris, Suzanne, O’Farrelly, Cliona, O’Mara, Shane M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101888/ https://www.ncbi.nlm.nih.gov/pubmed/21654873 http://dx.doi.org/10.2147/NDT.S13917 |
Ejemplares similares
-
Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort
por: Sugrue, Jamie A., et al.
Publicado: (2022) -
In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients
por: Bourke, Nollaig M, et al.
Publicado: (2014) -
Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature
por: Sugrue, Jamie A., et al.
Publicado: (2021) -
Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function
por: Piñeiro Fernández, Julián, et al.
Publicado: (2019) -
Designer human tissue: coming to a lab near you
por: Hay, David C., et al.
Publicado: (2018)